Multidisciplinary surgical treatment of clear-cell renal carcinoma with inferior vena cava tumor thrombus level III and IV: our experience during the past decade

Q4 Medicine Libri Oncologici Pub Date : 2020-12-21 DOI:10.20471/LO.2020.48.02-03.12
T. Hudolin, V. Ferenčak, L. Penezić, T. Zekulić, T. Kuliš, M. Marić, O. Pavlović, A. El-Saleh, N. Knezevic, E. Goluža, B. Biočina, Z. Kastelan
{"title":"Multidisciplinary surgical treatment of clear-cell renal carcinoma with inferior vena cava tumor thrombus level III and IV: our experience during the past decade","authors":"T. Hudolin, V. Ferenčak, L. Penezić, T. Zekulić, T. Kuliš, M. Marić, O. Pavlović, A. El-Saleh, N. Knezevic, E. Goluža, B. Biočina, Z. Kastelan","doi":"10.20471/LO.2020.48.02-03.12","DOIUrl":null,"url":null,"abstract":"Patients with non-metastatic, stage T3 clear-cell renal cell cancer present a clinical challenge for urologists. The extent of tumor thrombus in inferior vena cava is the primary determinant of surgical procedure complexity. Level III and IV thrombi require the use of cardiopulmonary bypass and hypothermic arrest. Careful preoperative planning and a multidisciplinary approach are mandatory. In this paper, we report outcomes of 12 patients who were surgically treated in our center. The 29 months overall survival for all patients was 69%, while three patients died during follow-up. Of nine surviving patients, six are currently disease-free, whereas three had disease progression. Our study showed that carefully selected patients with clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV could be successfully treated with an aggressive surgical approach.","PeriodicalId":53700,"journal":{"name":"Libri Oncologici","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Libri Oncologici","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20471/LO.2020.48.02-03.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Patients with non-metastatic, stage T3 clear-cell renal cell cancer present a clinical challenge for urologists. The extent of tumor thrombus in inferior vena cava is the primary determinant of surgical procedure complexity. Level III and IV thrombi require the use of cardiopulmonary bypass and hypothermic arrest. Careful preoperative planning and a multidisciplinary approach are mandatory. In this paper, we report outcomes of 12 patients who were surgically treated in our center. The 29 months overall survival for all patients was 69%, while three patients died during follow-up. Of nine surviving patients, six are currently disease-free, whereas three had disease progression. Our study showed that carefully selected patients with clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV could be successfully treated with an aggressive surgical approach.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
透明细胞肾癌合并下腔静脉肿瘤血栓III级和IV级的多学科外科治疗:我们近十年的经验
患有非味觉、T3期肾透明细胞癌症的患者对泌尿科医生来说是一个临床挑战。下腔静脉肿瘤血栓的程度是决定手术复杂性的主要因素。III级和IV级血栓需要使用体外循环和低温停搏。仔细的术前计划和多学科的方法是强制性的。在这篇论文中,我们报告了在我们中心接受手术治疗的12名患者的结果。所有患者29个月的总生存率为69%,而3名患者在随访中死亡。在9名幸存患者中,6人目前无病,3人病情进展。我们的研究表明,精心选择的下腔静脉肿瘤血栓等级为III和IV的透明细胞肾细胞癌患者可以通过积极的手术方法成功治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Libri Oncologici
Libri Oncologici Medicine-Oncology
CiteScore
0.30
自引率
0.00%
发文量
9
审稿时长
8 weeks
期刊介绍: - Genitourinary cancer: the potential role of imaging - Hemoglobin level and neoadjuvant chemoradiation in patients with locally advanced cervical carcinoma
期刊最新文献
Results of multicenter testing of PIK3CA somatic mutations in hormone-receptor positive HER2-negative advanced breast cancer Use of nasolabial flap for reconstruction of the floor of the mouth defects Hereditary breast and ovarian cancer – University Hospital of Split experiences Breast cancer radiotherapy - changes in fractionation schemes through decades Latest perspectives on the benefits of neoadjuvant therapy for patients with advanced gastric cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1